We are live on ! Find out more
Wolverine Trading

Wolverine Trading Portfolio holdings

AUM $139B
1-Year Est. Return 31.83%
This Fund
S&P 500
This Quarter Est. Return
+7.35%
1 Year Est. Return
+31.83%
3 Year Est. Return
+143.85%
5 Year Est. Return
+179.05%
10 Year Est. Return
AUM
$66B
AUM Growth
+$3.76B
Cap. Flow
+$3.39B
Cap. Flow %
5.14%
Top 10 Hldgs %
39.83%
Holding
5,507
New
1,014
Increased
1,383
Reduced
1,422
Closed
1,656

Sector Composition

Rank Sector Weight
1 Technology 1.75%
2 Consumer Discretionary 0.96%
3 Communication Services 0.94%
4 Healthcare 0.75%
5 Industrials 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FINV
3576
PUT
FinVolution Group
FINV
$1.16B
$50K ﹤0.01%
10,100
VNRX icon
3577
CALL
VolitionRx Ltd
VNRX
$9.46M
$50K ﹤0.01%
1,030
-70
-6% -$2.72K
ATYR
3578
aTyr Pharma
ATYR
$51.9M
$50K ﹤0.01%
+22,685
New +$53.5K
ABUS icon
3579
PUT
Arbutus Biopharma
ABUS
$873M
$49K ﹤0.01%
20,900
-6,400
-23% -$15.3K
ANGI icon
3580
CALL
Angi Inc
ANGI
$251M
$49K ﹤0.01%
2,070
-190
-8% -$4.25K
APT icon
3581
PUT
Alpha Pro Tech
APT
$50.6M
$49K ﹤0.01%
+12,100
New +$49.3K
COOK icon
3582
Traeger
COOK
$191M
$49K ﹤0.01%
+345
New +$57.7K
MVST icon
3583
CALL
Microvast
MVST
$288M
$49K ﹤0.01%
32,300
+5,300
+20% +$10.8K
QSI icon
3584
CALL
Quantum-Si Incorporated
QSI
$167M
$49K ﹤0.01%
26,800
+11,600
+76% +$29.9K
SGHC icon
3585
CALL
SGHC Ltd
SGHC
$7.07B
$49K ﹤0.01%
16,400
-3,500
-18% -$12.4K
ABUS icon
3586
CALL
Arbutus Biopharma
ABUS
$873M
$48K ﹤0.01%
20,600
-15,400
-43% -$36.8K
CGC
3587
Canopy Growth
CGC
$393M
$48K ﹤0.01%
2,098
-1,921
-48% -$59.2K
EQX icon
3588
Equinox Gold
EQX
$7.56B
$48K ﹤0.01%
14,734
-34,174
-70% -$118K
EVC icon
3589
PUT
Entravision Communication
EVC
$1.07B
$48K ﹤0.01%
10,000
-100
-1% -$490
SGMO
3590
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$48K ﹤0.01%
15,400
-3,200
-17% -$12.4K
UXIN
3591
CALL
Uxin Ltd
UXIN
$275M
$48K ﹤0.01%
+1,660
New +$59.6K
WRAP icon
3592
Wrap Technologies
WRAP
$110M
$48K ﹤0.01%
28,583
+10,437
+58% +$19K
BCLI
3593
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$47K ﹤0.01%
1,913
-1,974
-51% -$73.8K
CLBT icon
3594
Cellebrite
CLBT
$3.94B
$47K ﹤0.01%
+10,868
New +$48.5K
DRIO icon
3595
DarioHealth
DRIO
$67M
$47K ﹤0.01%
547
-567
-51% -$51K
REAL icon
3596
The RealReal
REAL
$1.53B
$47K ﹤0.01%
+37,801
New +$54.4K
SOND
3597
CALL
DELISTED
Sonder
SOND
$47K ﹤0.01%
1,905
-3,175
-63% -$112K
TK icon
3598
Teekay
TK
$977M
$46K ﹤0.01%
10,169
-15,225
-60% -$63.3K
NAK
3599
CALL
Northern Dynasty Minerals
NAK
$896M
$45K ﹤0.01%
202,400
+59,600
+42% +$14.4K
VHC icon
3600
VirnetX Holding Corp
VHC
$56.8M
$45K ﹤0.01%
1,720
-1,051
-38% -$26K

Similar funds

Wolverine Trading's Q4 2022 Portfolio in Review

As of Q4 2022, Wolverine Trading held 5,507 positions worth $66B, up 6% from $62.2B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Wolverine Trading deployed $3.39B of net new capital in Q4 2022, opening 1,014 new positions and adding to 1,383 existing holdings. Its largest new stake was KKR & Co: 2,839,800 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 1.7% of assets, up from 0.72% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Apple, an estimated $164M trimmed.

  • Wolverine Trading's largest Q4 2022 buy was KKR & Co: 2,839,800 shares worth $132M.
  • Wolverine Trading added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $480M increase.
  • Wolverine Trading's biggest Q4 2022 reduction was Apple, cutting an estimated $164M.
  • Wolverine Trading fully exited Tesla in Q4 2022, selling an estimated $93.7M.
  • Wolverine Trading's ten largest holdings make up 40% of its $66B portfolio in Q4 2022.
  • Wolverine Trading opened 1,014 new positions and closed 1,656 in Q4 2022.
  • Wolverine Trading's portfolio value rose 6% quarter-over-quarter to $66B.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.